The Cooper Companies, Inc.’s COO strategic investments in innovation and its diversified product base support long-term growth. However, near-term macro and inventory challenges, particularly in ...

Private label brands continued to gain traction with consumers during the first six months of 2025, according to the Private ...

According to First Insight's "The Quiet Takeover of Private Label," nearly three-quarters (71%) of consumers surveyed ...

Cencora, Inc. (NYSE:COR)’s shares have gained 32.30% year-to-date as the firm has benefited from being insulated against tariffs and the Most Favored Nation drug policy.

Shares of Cencora Inc. COR shed 1.16% to $294.38 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.54% to 6,297.36 and the ...

Private label’s adoption rate continues to soar as even the wealthiest consumers prioritize value, yet despite the uptick in private label sales, retailers rely on name brands to generate sales ...

Some grocery stores sell store-brand products at discount prices. Most are cagey about where these products come from, and ...

Looking at departments, store brand dollar sales for the 52 weeks ending June 15 increased in seven of nine sections, led by Refrigerated, which was up 13%, followed by Beverages, (+4.8%), Frozen (+3.

Store brands are opening a door for younger consumers to obtain affordable luxuries, per a new report.

Cencora, Inc. (NYSE:COR) is an American pharmaceutical and healthcare services provider. It is a rare stock in its peers that is in the green this year. Cencora, Inc.

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2025 on Wednesday, August 6, 2025, prior to the opening of trading on the New York ...

Cencora’s five-year average ROIC was 57.3%, placing it among the best healthcare companies. This illustrates its management team’s ability to invest in highly profitable ventures and produce ...